Literature DB >> 18020546

Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis.

Roman Fiedler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18020546     DOI： 10.2165/00044011-200727120-00010

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  7 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Mortality risk among hemodialysis patients receiving different vitamin D analogs.

Authors:  F Tentori; W C Hunt; C A Stidley; M R Rohrscheib; E J Bedrick; K B Meyer; H K Johnson; P G Zager
Journal:  Kidney Int       Date:  2006-10-04       Impact factor: 10.612

3.  Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men.

Authors:  Lisbet Brandi; Martin Egfjord; Klaus Olgaard
Journal:  Nephrol Dial Transplant       Date:  2002-05       Impact factor: 5.992

Review 4.  Health-economic comparison of paricalcitol, calcitriol and alfacalcidol for the treatment of secondary hyperparathyroidism during haemodialysis.

Authors:  Hubertus Rosery; Rito Bergemann; Steven E Marx; Axel Boehnke; Joel Melnick; Raimund Sterz; Laura Williams
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

5.  Paricalcitol-treated patients experience improved hospitalization outcomes compared with calcitriol-treated patients in real-world clinical settings.

Authors:  Deborah G Dobrez; Angelo Mathes; Michael Amdahl; Steven E Marx; Joel Z Melnick; Stuart M Sprague
Journal:  Nephrol Dial Transplant       Date:  2004-03-05       Impact factor: 5.992

6.  Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

Authors:  Ming Teng; Myles Wolf; Edmund Lowrie; Norma Ofsthun; J Michael Lazarus; Ravi Thadhani
Journal:  N Engl J Med       Date:  2003-07-31       Impact factor: 91.245

Review 7.  Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.

Authors:  Florent Richy; Olivier Ethgen; Olivier Bruyere; Jean-Yves Reginster
Journal:  Osteoporos Int       Date:  2004-01-22       Impact factor: 4.507
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.